Advertisements


Galapagos Ends Enrollment in Osteoarthritis Study Before Time

Galapagos (GLPG) closes enrollment in the phase II study on GLPG1972/S201086 for the treatment of patients with osteoa.....»»

Category: personnelSource: nytJun 12th, 2019

Mallinckrodt Ends Enrollment in Phase III for Terlipressin

Mallinckrodt (MNK) concludes enrollment in the phase III study on terlipressin, currently under development for treating adult patients with Hepatorenal .....»»

Category: dealsSource: nytMay 15th, 2019

Inovio Closes Enrollment in Brain Cancer Study Before Time

Zacks.....»»

Category: topSource: redinewsApr 2nd, 2019

Inovio Closes Enrollment in Brain Cancer Study Before Time

Inovio (INO) concludes enrollment in the phase I/II study on INO-5401+INO-9012 combined with Regeneron/Sanofi's Libtayo for the newly-diagnosed subjects with glioblastoma prior t.....»»

Category: personnelSource: nytApr 2nd, 2019

Servier and Galapagos begin global Phase 2 study for osteoarthritis treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 26th, 2018

The best time to exercise is before breakfast, a new study says

Quinn Rooney/Getty Images A new study found that overweight men who exercised before eating breakfast burned twice the fat of those who exercise.....»»

Category: topSource: businessinsider6 hr. 54 min. ago

More work, more sleep: New study offers glimpse of daily life as a millennial

Millennials are more educated than earlier generations. And in their leisure time, they’re more likely to whip out the games......»»

Category: topSource: washpost9 hr. 24 min. ago

Take a rare look inside architect Edward Killingsworth"s Long Beach home

Renowned for his Case Study Houses and other landmark projects, the architect built his family a home that served as an exemplar of his work manipulating glass, light, air and space. The Killingsworth house is changing hands for the first time. .....»»

Category: topSource: latimes12 hr. 9 min. ago

Market Snapshot: S&P 500 ends within 1% of all-time high amid Brexit draft deal, quarterly results

Stock indexes on Thursday lost steam in the final minutes but finish near records, booking slight gains as investors drew optimism from a Brexit and strong earnings......»»

Category: topSource: marketwatchOct 17th, 2019

7 things you might not realize teachers have to do after the school day ends

Craig F. Walker/The Boston Globe via Getty Images Teaching can be an extremely time-consuming career.  Though the average American school day is on.....»»

Category: topSource: businessinsiderOct 17th, 2019

Dow closes up less than 0.1%; S&P 500 ends up 0.3%

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 17th, 2019

S&P 500 ends 0.2% lower; Nasdaq Composite off 0.3%

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 16th, 2019

A Crucial Major Depressive Disorder Study Is About to Be Underway

Axsome Therapeutics shares made a handy gain on Wednesday after the firm announced that it has completed patient enrollment in its Gemini study, a Phase 3 trial of AXS-05 in patients with major........»»

Category: blogSource: 247wallstOct 16th, 2019

Novavax kicks off late-stage trial for new seasonal flu vaccine

Novavax Inc. has officially started a late-stage clinical trial for its seasonal flu vaccine, a critical phase for the Gaithersburg biotech vying for a much-needed win this time around. The company is launching the phase 3 study for NanoFlu, its seas.....»»

Category: topSource: bizjournalsOct 15th, 2019

Can-Fite BioPharma completes enrollment in Phase II NASH study of Namodenoson

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 15th, 2019

New Osteoarthritis Treatment Has to Wait Even Longer for FDA Approval

Flexion Therapeutics has announced that the FDA needs additional time to complete the review of its osteoarthritis knee pain treatment......»»

Category: blogSource: 247wallstOct 14th, 2019

S&P 500 ends higher by more than 0.6%

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 10th, 2019

DOJ ends probe into Fulton Bank over possible discriminatory lending

The company said federal officials have “determined that the circumstances do not require enforcement action by the Department at this time.”.....»»

Category: topSource: bizjournalsOct 9th, 2019

Dow ends with 300-point loss as U.S.-China trade hopes falter

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 8th, 2019

Nymex November WTI oil ends 12 cents lower at $52.63 a barrel, down 0.2%

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 8th, 2019

S&P 500 ends 0.5% lower; Nasdaq Composite down 0.3%

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 7th, 2019